Intrinsic Value of S&P & Nasdaq Contact Us

Elevation Oncology, Inc. ELEV NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
41/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.00
+2365.8%

Stock Statistics — ELEV

Elevation Oncology, Inc. (ELEV) has a market capitalization of $21.63M and trades at $0.37. The 52-week range is 0.221-3.09.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.5, Earnings Per Share (EPS) of $-0.78.

The stock has a beta of 1.50, operates in the Healthcare sector.

Trading Data
Current Price$0.37
52-Week Range0.221-3.09
Volume4.82M
Avg Volume (30D)1.35M
Market Cap$21.63M
Beta (1Y)1.50
Company
IPO Date2021-06-25
Employees34
CEOJoseph J. Ferra Jr.
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS28623U1016
CUSIP28623U101
Income (Latest Year)
EBITDA$-44.7M
Operating Income$-44.7M
Net Income$-44.49M
EPS$-0.78
EPS Diluted$-0.78
Shares Outstanding$57.28M
Balance Sheet (Latest Year)
Total Assets$95.63M
Current Assets$94.73M
Cash & ST Investments$93.18M
Total Liabilities$35.6M
Total Debt$31.13M
Net Debt$-18.33M
Total Equity$60.03M
Debt / Equity0.52
Valuation Ratios
P/E Ratio-0.5
P/B Ratio0.36
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message